TRF1 averts chromatin remodelling, recombination and replication dependent-Break Induced Replication at mouse telomeres

  1. Rosa Maria Porreca
  2. Emilia Herrera-Moyano
  3. Eleni Skourti
  4. Pui Pik Law
  5. Roser Gonzalez Franco
  6. Alex Montoya
  7. Peter Faull
  8. Holger Kramer
  9. Jean-Baptiste Vannier  Is a corresponding author
  1. MRC London Institute of Medical Sciences, United Kingdom
  2. The Francis Crick Institute, United Kingdom

Abstract

Telomeres are a significant challenge to DNA replication and are prone to replication stress and telomere fragility. The shelterin component TRF1 facilitates telomere replication but the molecular mechanism remains uncertain. By interrogating the proteomic composition of telomeres, we show that mouse telomeres lacking TRF1 undergo protein composition reorganisation associated with the recruitment of DNA damage response and chromatin remodellers. Surprisingly, mTRF1 suppresses the accumulation of promyelocytic leukemia (PML) protein, BRCA1 and the SMC5/6 complex at telomeres, which is associated with increased Homologous Recombination (HR) and TERRA transcription. We uncovered a previously unappreciated role for mTRF1 in the suppression of telomere recombination, dependent on SMC5 and also POLD3 dependent Break Induced Replication at telomeres. We propose that TRF1 facilitates S-phase telomeric DNA synthesis to prevent illegitimate mitotic DNA recombination and chromatin rearrangement.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures.Proteomic data have been made available at PRIDE, under the accession code PXD017022.

The following data sets were generated

Article and author information

Author details

  1. Rosa Maria Porreca

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Emilia Herrera-Moyano

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Eleni Skourti

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Pui Pik Law

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8924-0462
  5. Roser Gonzalez Franco

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Alex Montoya

    Biological Mass Spectrometry and Proteomics Facility, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Peter Faull

    Proteomics Mass Spectrometry Science and Technology Platform, The Francis Crick Institute, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8491-8086
  8. Holger Kramer

    Biological Mass Spectrometry and Proteomics Facility, MRC London Institute of Medical Sciences, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Jean-Baptiste Vannier

    Telomere Replication and Stability Group, MRC London Institute of Medical Sciences, London, United Kingdom
    For correspondence
    j.vannier@lms.mrc.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4471-1854

Funding

European Commission (637798 MetDNASecStr)

  • Pui Pik Law

Medical Research Council (MRC Career Development Award)

  • Emilia Herrera-Moyano
  • Pui Pik Law
  • Roser Gonzalez Franco
  • Alex Montoya
  • Holger Kramer
  • Jean-Baptiste Vannier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Porreca et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,311
    views
  • 550
    downloads
  • 24
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rosa Maria Porreca
  2. Emilia Herrera-Moyano
  3. Eleni Skourti
  4. Pui Pik Law
  5. Roser Gonzalez Franco
  6. Alex Montoya
  7. Peter Faull
  8. Holger Kramer
  9. Jean-Baptiste Vannier
(2020)
TRF1 averts chromatin remodelling, recombination and replication dependent-Break Induced Replication at mouse telomeres
eLife 9:e49817.
https://doi.org/10.7554/eLife.49817

Share this article

https://doi.org/10.7554/eLife.49817